Center for Cancer Care, Inc., P.C.

New Albany, Indiana 47150

0 studies enrolling now · 9 studies all time

What they study most

Colorectal Cancer, Head and Neck Cancer, Lymphoma, B-Cell, Metastatic Breast Cancer, Non-Small Cell Lung Cancer, Ovarian Cancer, Rectal Cancer, Small Cell Lung Cancer

Studies at this site

• Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer — Stopped early
• Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer — Completed
• Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer — Completed
• Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer — Completed
• Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal Cancer — Completed
• Rituximab and Gemcitabine for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma — Stopped early
• Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer — Stopped early
• A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer — Completed
• Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & Neck — Stopped early